ORKA Q4 2020 Earnings — Oruka Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

ORKAOruka Therapeutics, Inc.

$1B

Q4 2020 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

-$16,000

Operating Income

-$5M

Net Income

-$5M

EPS (Diluted)

$-6.44

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$3M

Free Cash Flow

-$3M

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$50M

Total Liabilities

$4M

Stockholders' Equity

$47M

Cash & Equivalents

$49M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	-$16,000	-$24,000	+33.3%
Operating Income	-$5M	-$1M	-301.1%
Net Income	-$5M	-$1M	-318.0%